PriceTargets.com logo

MedAvail - MDVL Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.00 As of 02/13/2024 12:59 AM ET
+0 (0.00%)
Get New MedAvail Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MDVL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MDVL

Analyst Price Target is $0.00
This price target is based on 0 analysts offering 12 month price targets for MedAvail in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.

This chart shows the closing price for MDVL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in MedAvail. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/24/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/22/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/22/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/21/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/19/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/17/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/17/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/16/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/27/2023Lake Street CapitalLower Target$4.00 ➝ $1.00Low
8/22/2022CowenBoost Target$5.00Low
8/12/2022Lake Street CapitalLower Target$8.00 ➝ $4.00Low
8/30/2021CowenLower TargetOutperform$20.00 ➝ $9.50High
8/12/2021Lake Street CapitalDowngradeBuy ➝ In-Line$18.00 ➝ $8.00High
4/12/2021CowenBoost TargetOutperform$18.00 ➝ $20.00High
4/5/2021CowenBoost TargetOutperform$17.00 ➝ $18.00Medium
12/14/2020Lake Street CapitalInitiated CoverageBuyLow
12/14/2020CowenInitiated CoverageOutperformHigh
(Data available from 4/16/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/19/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/19/2023
  • 1 very positive mentions
  • 2 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
11/18/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/18/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/17/2024
  • 0 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
2/16/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/17/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/16/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
MedAvail logo
MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, and kiosk solutions in the United States and Canada. It offers a pharmacy technology solution, including the MedAvail MedCenter, which enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. The company is headquartered in Phoenix, Arizona. On February 2, 2024, MedAvail Holdings, Inc along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $3.31
Low: $1.80
High: $5.95

52 Week Range

Now: N/A

Volume

245,100 shs

Average Volume

261,432 shs

Market Capitalization

$2.91 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.76

Frequently Asked Questions

What sell-side analysts currently cover shares of MedAvail?

The following equities research analysts have issued research reports on MedAvail in the last year:
View the latest analyst ratings for MDVL.

What is the current price target for MedAvail?

0 Wall Street analysts have set twelve-month price targets for MedAvail in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for MedAvail in the next year.
View the latest price targets for MDVL.

What is the current consensus analyst rating for MedAvail?

MedAvail currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for MDVL.

What other companies compete with MedAvail?

Other companies that are similar to MedAvail include CohBar, Quoin Pharmaceuticals, Kiromic BioPharma, Altamira Therapeutics and IMAC. Learn More about companies similar to MedAvail.

How do I contact MedAvail's investor relations team?

MedAvail's physical mailing address is 45 HORSEHILL ROAD SUITE 106, CEDAR KNOLLS NJ, 07927. The company's listed phone number is (905) 812-0023 and its investor relations email address is [email protected]. The official website for MedAvail is www.medavail.com. Learn More about contacing MedAvail investor relations.